Skip to main content
Cureus logoLink to Cureus
. 2024 Jan 19;16(1):e52544. doi: 10.7759/cureus.52544

Is There an Over-Indication for Elective Tracheostomy in Patients With Oral Cavity Cancer?

Diana Breda 1,, Sara Martins 2, Ana Millán 3, Sandra Bitoque 3, Carlos Zagalo 3, Pedro Gomes 3
Editors: Alexander Muacevic, John R Adler
PMCID: PMC10874489  PMID: 38371034

Abstract

Objectives: Temporary tracheostomies (TT) are often used in oral oncologic surgery to secure the postoperative airway. Our primary objective was to determine if there was an over-indication for elective tracheostomy in our population. If so, our secondary objective was to ascertain which patients could have possibly avoided TT.

Materials and methods: We performed a retrospective study of patients with oral and oropharyngeal squamous cell carcinoma in which resection with curative intent and TT were performed. Variables collected included demographics, comorbidities, and complications. Additionally, we retrospectively applied the Cameron and TRACHY tracheostomy scoring systems to evaluate overall tracheostomy recommendations.

Results: A total of 116 elective tracheostomies were performed between January 2019 and December 2020. According to the Cameron and TRACHY scoring systems, recommendations for tracheostomy coincided in only 54.3% and 45.7%, respectively. Tumor anatomy and type of reconstruction were associated with less time until decannulation. Additionally, in patients without TT recommendation determined by both scores with tumor anatomy and location, as well as T and N stages were also associated with less time until decannulation.

Conclusion: There appears to be an over-indication for elective tracheostomy in our patients with oral cavity and oropharyngeal cancer. The patients that could have potentially avoided elective TT were those with lateral anatomy, without flap or with fasciocutaneous flap, location in the mandibular alveolus or anterior tongue, as well as N0/N1 and T1/T2 patients.

Keywords: elective tracheostomy, head and neck cancer, oral cancer, complications, tracheostomy scoring system

Introduction

Patients who undergo oral cavity cancer resection and reconstruction require special attention when it comes to airway management, due to altered anatomy as well as the peri- and postoperative risk of bleeding, swelling, and aspiration. Elective temporary tracheostomy (TT) is the most widely used approach for airway management following oral and oropharyngeal cancer surgery [1]. However, studies indicate that not all patients require elective TT, advocating that the complications outweigh the benefits of this technique [2]. The duration of hospitalization after oral cancer surgery is also often used as an argument against tracheotomy since a longer hospitalization leads to higher costs [3].

Screening based on the tracheostomy scores is helpful in predicting patients who do not need tracheostomy and can act as a reliable screening tool in the preoperative planning of the airway. They aid in reducing the incidence of postoperative tracheostomies and consequently, the complications associated with this technique. Patients are managed more carefully, with reduced morbidity and mortality [4].

Our study aims to evaluate the morbidity associated with elective tracheostomy in patients undergoing oral and oropharyngeal tumor resection and to determine if there was an over-indication for elective TT in a specialized oncologic institute.

Materials and methods

Study cohort

We conducted a retrospective review of patients who underwent tumor resection and elective tracheostomy between January 2019 and December 2020 at the Head and Neck Surgery Department at the Portuguese Oncology Institute of Lisbon. Patient characteristics, including age, sex, ASA (American Society of Anesthesiologists) grade, primary tumor site, tumor-node-metastasis (TNM) classification, the extent of resection, use of flaps/type of reconstruction, complications, and time to decannulation, were collected retrospectively from hospital medical records, clinical letters, imaging, as well as operative and pathology records. We only included patients who were 18 years of age or above with squamous carcinoma cells (SCCs) of the oral cavity and oropharyngeal area who underwent tumor resection and elective tracheostomy with curative intent. Every type of reconstruction was considered. The T and N stages were determined by clinical examination, contrast-enhanced computed tomography, magnetic resonance imaging, and positron emission tomography-computed tomography (PET) scan. Time to TT decannulation was also registered and patients were divided into two groups - one group with decannulation ≤7 days and the other with decannulation >7 days after surgery. While the duration of TT varies significantly among patients with no defined optimal timeframe, we defined these two groups considering that decannulation typically takes place approximately seven to 10 days after the surgical procedure, and a delay of decannulation is considered by some authors as one that occurs more than seven days after surgery [5]. Patients with minor oral surgical procedures (diagnostic laryngoscopy, biopsy, etc.), redo surgery, emergency surgery, non-oral cancer surgery, patients with a pre-existing TT, patients undergoing partial or total laryngectomy, and those undergoing laryngectomy were excluded.

Airway management

The decision to perform a tracheostomy was made by the consultant surgeons and anesthesiologists without the use of scoring systems. Elective tracheostomy was performed through a horizontal midline incision, blunt dissection to the trachea, and horizontal incision of the membrane between the second or third tracheal cartilage. Standard tracheostomy tubes with cuffs were used. All tracheostomy procedures were performed by a surgical team from our department.

Tracheostomy scoring systems

We compared and studied two current scoring systems published in the literature. The first is published by Cameron et al., which concentrates on four principal domains: tumor site (cutaneous, oral cavity, or oropharynx), mandibulectomy, bilateral neck dissection, and reconstruction. Elective tracheostomy is recommended for patients with a score of ≥5 [6]. The other scoring system used was the TRACHY score, published by Mohamedbhai et al., which focused on T-stage, reconstruction, anatomy, coexisting conditions, history, and neck dissection. In this case, elective tracheostomy is recommended for those with a score of ≥4 [4]. The collected data was converted and arranged according to the tracheostomy scores based on the scoring systems. Detailed parameters of the evaluated scores are shown in Table 1 and Table 2.

Table 1. The collected data as per scoring systems - Cameron score.

RFFF, radial forearm free flap

Cameron score
Variables Score
Tumor site  
   Cutaneous 0
   Oral cavity  
      Buccal mucosa 0
      Maxilla 0
      Mandibular alveolus 1
      Anterior tongue 1
      Floor of mouth 2
   Oropharynx  
      Soft palate 3
      Anterior pillar 3
      Tonsillar pillar 4
      Posterior tongue 4
Mandibulectomy  
   No 0
   Yes 1
Bilateral neck dissection  
   No 0
   Yes 3
Reconstruction  
   None 0
   RFFF 2
   Other 3
Tracheostomy recommended ≥ 5

Table 2. The collected data as per scoring systems - TRACHY score.

ASA, American Society of Anesthesiologists

TRACHY score  
Variables Score
T-stage  
   T1-T2 0
   T3-T4 1
Reconstruction  
   Fasciocutaneous 0
   Myocutaneous or composite 1
   Two flaps 3
Anatomy  
   Lateral or central 0
   Anterior or oropharyngeal 2
Coexisting conditions  
   ASA 1 and ASA 2 0
   ASA 3 1
History  
   None 0
   Previous operation on the head and neck 1
   Previous radiotherapy to the head and neck 3
Neck dissection  
   None 0
   Unilateral 0
   Bilateral 3
Tracheostomy recommended ≥4

Statistical methods

Data analysis was performed using SPSS version 22 software (IBM SPSS Inc., Chicago, IL). Data was presented in the results as median with standard deviation unless otherwise specified. Analysis of demographic and clinical data was presented with descriptive statistics. The chi-square test was used to assess associations between nominal variables, whereas the Mann-Whitney U test was used to compare the means of variables of two independent groups. Results with P<0.05 were considered statistically significant.

Results

From January 2019 to December 2020, 116 patients were included in the study. The mean age was 63.8 years (range: 39-91), with a total of 91 (78.4%) males and 25 (21.6%) females (Table 3).

Table 3. Patient characteristics.

  n (%)
Mean age (years) 63.8
   Range (years) 39-91
Sex
   Male 91 (78.4%)
   Female 25 (21.6%)
Smoker
   Yes 74 (63.8%)
   No 42 (36.2%)
ASA grade
   I 3 (2.6%)
   II 75 (64.7%)
   III 38 (32.8%)

Nine different tumor locations were recorded, the most common being the tongue (37.9%), mandibular alveolus (22.4%), and floor of mouth (19.8%) (Table 4).

Table 4. Surgical details.

  n (%)
Tumor site  
   Anterior tongue 44 (37.9)
   Mandible 26 (22.4)
   Floor 23 (19.8)
   Mucosa  9 (7.80)
   Tonsil 5 (4.3)
   Maxilla  4 (3.4)
   Base of the tongue 3 (2.6)
   Palate 1 (0.9)
T stage  
   T1 7 (6.0)
   T2 46 (39.7)
   T3 33 (28.4)
   T4 30 (25.9)
N stage  
   N1 22 (19.0)
   N2 32 (27.6)
   N3 12 (10.3)
   N0 50 (43.1)
Type of resection  
   Without mandibulectomy 62 (53.4)
   Marginal mandibulectomy 30 (25.9)
   Segmental mandibulectomy 24 (20.7)
Type of neck dissection  
   None 3 (2.6)
   Unilateral 68 (58.6)
   Bilateral 45 (38.8)
Reconstruction  
   Without  37 (31.9)
   With flap 79 (68.1)
Type of reconstruction  
   None or fascioctaneous 87 (75.0)
   Myocutaneous or composite 12 (10.3)
   Two flaps 17 (14.7)

Of the 116 patients, 103 (88.8%) underwent resection of more than one site. For reconstruction, 37 patients (31.9%) had no flap with only primary closure, while 79 patients underwent tumor resection with flap reconstruction, of which 35 with microvascular free flap. The radial forearm flap (RFF) was most frequently used (24.1%, 28 patients); other approaches involved a combination of tongue (16 patients), pectoral (10), nasolabial (10), cervical (10), fibula (7), buccal fat pad (7), jugal advancement, and sternocleidomastoid muscle (1) flaps.

Tracheostomy-associated complications were observed in 14 patients (12.2%), most commonly pneumonia (Table 5).

Table 5. Tracheostomy-associated complications.

Type of complication n (%)
Pneumonia 8 (6.9)
Obstruction 5 (4.3)
Hemorrhage at tracheostomy site 2 (1.7)
Tracheobronchitis 2 (1.7)
Emphysema 1 (0.9)

In four patients, both pneumonia and TT obstruction were denoted postoperatively. There were no lethal complications associated with TT in our study. However, two patients did die during hospitalization, one due to medical complications and another with progressive paraneoplastic syndrome.

The length of postoperative hospitalization ranged from two to 82 days with a median of 11 days. As anticipated a significant difference was found in the duration of hospitalization in patients with TT-associated complications, with these having a significantly longer stay after surgery (22 vs. 10.5 days) (p<0.01).

In order to evaluate if there was an over-indication for elective TT, we applied two scoring systems to our population. According to the Cameron scoring system and the TRACHY score, recommendations for tracheostomy coincided with only 56% and 45.7%, respectively. The median scores of our cohort were five for the Cameron scoring system and three for the TRACHY score. Additionally, scores of zero and one were found in 21 patients for the Cameron score and in 38 patients for the TRACHY score.

Regarding decannulation time, 107 of the 116 patients who underwent tracheostomy were decannulated during hospitalization, with a median of seven days until decannulation, varying from two days to 66 days. As stated previously, patients were divided into two groups - one group in which decannulation occurred in ≤7 days and the other with decannulation >7 days after surgery. We hypothesized that individuals in the group with less time until decannulation were likely those who might have been able to forego elective TT. Subsequently, we sought to discern the distinguishing characteristics of these patients who could have avoided elective TT and in order to accomplish this, we conducted two distinct analyses (Figure 1).

Figure 1. Study workflow for patients that could have avoided elective TT.

Figure 1

In the first analysis, we compared both groups to determine what variables were significantly associated with less time until decannulation. As expected, we found that having postoperative TT-associated complications was significantly associated with more time until decannulation. In order to correctly determine what preoperative and operative characteristics were linked to less time until decannulation, we opted to exclude this post-operative variable. Therefore, we analyzed the 74 patients without postoperative complications and found a significant association between time until decannulation and anatomy (p=0.045), as well as the type of reconstruction (p=0.004). We observed that patients with lateral anatomy and with primary closure or a fasciocutaneous flap were significantly associated with less time until decannulation (Table 6).

Table 6. Patients without postoperative complications .

ASA, American Society of Anesthesiologists

                          Duration group  
Variables ≤7 days >7 days P-value
  n (%) n (%)  
Age     0.42
   <65 25 (55.6) 12 (42.9)  
   ≥65 20 (44.4) 16 (57.1)  
Sex     0.179
   Male 31 (68.9) 24 (85.7)  
   Female 14 (31.1) 4 (14.3)  
ASA     0.791
   I/II 30 (66.7) 17 (60.7)  
   III 15 (33.3) 11 (39.3)  
Smoker     1.0
   Yes 27 (60.0) 16 (57.1)  
   No 18 (40.0) 12 (42.9)  
Comorbidities     1.0
   Yes 33 (73.3) 21 (75.0)  
   No 12 (26.7) 7 (25.0)  
Anatomy     0.045
   Lateral 38 (84.4) 17 (60.7)  
   Anterior 7 (15.6) 11 (39.3)  
Tumor Site     0.439
   Bucal mucosa, maxilla 4 (8.9) 4 (14.3)  
   Mandibular alveolus, anterior tongue 31 (68.9) 17 (60.7)  
   Floor 7 (15.6) 4 (14.3)  
   Soft palate, anterior pillar 0 (0) 2 (7.1)  
   Tonsillar pillar, posterior tongue 3 (6.7) 1 (3.6)  
T stage     0.552
   T1/T2 27 (60.0) 14 (50.0)  
   T3/T4 18 (40.0) 14 (50.0)  
N stage     0.165
   N0/N1 34 (75.6) 16 (57.1)  
   N2/N3 11 (24.4) 12 (42.9)  
Mandibulectomy     0.165
   Yes 11 (24.4) 12 (42.9)  
   No 34 (75.6) 16 (57.1)  
Neck dissection     0.240
   None/unilateral 33 (73.3) 16 (57.1)  
   Bilateral 12 (26.7) 12 (42.9)  
Reconstruction     0.075
   Yes 23 (51.1) 21 (75.0)  
   No 22 (48.9) 7 (25.0)  
Type of reconstruction     0.004
   None or fasciocutaneous 41 (91.1) 18 (64.3)  
   Myocutaneous or composite 0 (0) 5 (17.9)  
   Two flaps 4 (8.9) 5 (17.9)  

In a second analysis, we studied the patients in which TT was not recommended by both scoring systems (Table 7 and Table 8).

Table 7. Number of patients without a recommendation for elective TT based on Cameron score.

ASA, American Society of Anesthesiologists; TT, temporary tracheostomy

                         Duration group  
Variables ≤7 days >7 days P-value
  n (%) n (%)  
Age     0.387
   <65 19 (54.3) 7 (38.9)  
   ≥65 16 (45.7) 11 (61.1)  
Sex     0.555
   Male 22 (62.9) 13 (72.2)  
   Female 13 (37.1) 5 (27.8)  
ASA     0.359
   I/II 25 (71.4) 10 (55.6)  
   III 10 (28.6) 8 (44.4)  
Smoker     0.569
   Yes 17 (48.6) 7 (38.9)  
   No 18 (51.4) 11 (61.1)  
Comorbidities     0.296
   Yes 26 (74.3) 16 (88.9)  
   No 9 (25.7) 2 (11.1)  
Anatomy     0.014
   Lateral 33 (94.3) 12 (66.7)  
   Anterior 2 (5.7) 6 (33.3)  
Local     0.031
   Bucal mucosa, maxilla 4 (11.4) 7 (38.9)  
   Mandibular alveolus, anterior tongue 30 (85.7) 11 (61.1)  
   Floor 1 (2.9) 0  
   Soft palate, anterior pillar 0 0  
   Tonsillar pillar, posterior tongue 0 0  
T stage     0.017
   T1/T2 25 (71.4) 6 (33.3)  
   T3/T4 10 (28.6) 12 (66.7)  
N stage     0.031
   N0/N1 31 (88.6) 11 (61.1)  
   N2/N3 4 (11.4) 7 (38.9)  
Mandibulectomy     0.719
   Yes 6 (17.1) 4 (22.2)  
   No 29 (82.9) 14 (77.8)  
Neck dissection     1.000
   None/unilateral 33 (94.3) 17 (94.4)  
   Bilateral 2 (5.7) 1 (5.6)  
Reconstruction     0.249
   Yes 13 (37.1) 10 (55.6)  
   No 22 (62.9) 8 (44.4)  
Type of reconstruction     0.108
   None or fasciocutaneous 34 (97.1) 15 (83.3)  
   Myocutaneous or composite 0 0  
   Two flaps 1 (100.0) 3 (16.7)  

Table 8. Number of patients without a recommendation for elective TT based on TRACHY score.

ASA, American Society of Anesthesiologists; TT, temporary tracheostomy

                                  Duration group  
Variables ≤7 days >7 days P-value
  n (%) n (%)  
Age     0.441
   <65 20 (52.6) 16 (64.0)  
   ≥65 18 (47.4) 9 (36.0)  
Sex     0.239
   Male 26 (68.4) 21 (84.0)  
   Female 12 (31.6) 4 (16.0)  
ASA     1.000
   I/II 29 (76.3) 19 (76.0)  
   III 9 (23.7) 6 (24.0)  
Smoker     0.441
   Yes 20 (52.6) 16 (64.0)  
   No 18 (47.4) 9 (36.0)  
Comorbidities     0.575
   Yes 28 (73.7) 16 (64.0)  
   No 10 (26.3) 9 (36.0)  
Anatomy     <0.001
   Lateral 35 (92.1) 13 (52.0)  
   Anterior 3 (7.9) 12 (48.0)  
Local (score)     0.031
   Bucal Mucosa, maxilla 2 (5.3) 6 (24.0)  
   Mandibular alveolus, anterior tongue 31 (81.6) 15 (60.0)  
   Floor 3 (7.9) 0  
   Soft palate, anterior pillar 0 1 (4.0)  
   Tonsillar pillar, posterior tongue 2 (5.3) 3 (12.0)  
T stage     0.419
   T1/T2 27 (71.1) 15 (60.0)  
   T3/T4 11 (28.9) 10 (40.0)  
N stage     0.001
   N0/N1 33 (86.8) 12 (48.0)  
   N2/N3 5 (13.2) 13 (52.0)  
Mandibulectomy     0.262
   Yes 9 (23.7) 10 (40.0)  
   No 29 (76.3) 15 (60.0)  
Neck dissection     0.292
   None/unilateral 37 (97.4) 22 (88.0)  
   Bilateral 1 (2.6) 3 (12.0)  
Reconstruction     0.071
   Yes 18 (47.4) 18 (72.0)  
   No 20 (52.6) 7 (28.0)  
Type of reconstruction     0.557
   None or fasciocutaneous 37 (97.4) 23 (92.0)  
   Myocutaneous or composite 1 (2.6) 2 (8.0)  
   Two flaps 0 0  

In the 53 patients without TT indication in the Cameron scoring system and the 63 patients in the TRACHY score, we found a significant association between time until decannulation and anatomy (Cameron, p=0.014; TRACHY, p<0.001 ), as well as site (Cameron, p=0.031; TRACHY, p=0.031) and N stage (Cameron, p=0.031; TRACHY, p=0.001). In the Cameron score, a significant association was also found with the T stage (p=0.017). Patients with lateral anatomy, N0-N1 and location in the mandibular alveolus, and anterior tongue were associated with less time until decannulation for both scores. Additionally, the T1/T2 stage was also associated with less time until decannulation in the Cameron score.

Discussion

Treatment of oncology patients begins with the decision on required therapy and ends in tumor aftercare. Due to the high risk of postoperative aspirate, bleeding, and swelling, patients who undergo oral cancer surgery need individual consideration when it comes to airway management, and the most commonly used approach for these patients is elective TT [1].

When considering an elective TT, it is imperative to evaluate if the possible complications associated with TT outweigh its benefits. In the literature, these complications vary substantially, with a range of 8-45% [2,7-11]. In our study, we had 12.1% of TT-associated complications, which is on the lower end of what is described in the literature. The included cases were of pneumonia, obstruction of the cannula, bleeding, tracheobronchitis, and emphysema, which coincided with the most common complications recorded in the literature [12,13]. We did not find any lethal complications associated with TT, as described in other studies; nor did we have any cases of pulmonary atelectasis, respiratory failure, dislocation of the cannula, or pneumothorax [14,15].

Arguments against elective TT often mention hospitalization duration, seeing as longer stays are associated with greater costs, as mentioned previously, as well as a higher risk of hospital-acquired infections, and sleep deprivation, in addition to mental and physical deconditioning [3]. In our study, we had a hospital stay median of 11±10.3 days, ranging from two to 82 days with patients with TT-associated complications having a significantly longer hospital stay after surgery (22 days). Other studies reference hospital stays of 14-15 days and as expected, observe similar results with complications increasing the duration of hospitalization [7,8]. In our institution, hospital stay is also commonly increased due to social issues as well as patients living far from the hospital. We believe that preoperative optimization with social services, which are now in place, will improve these, and future studies should introduce these issues as possible influencing variables. However, despite the possible complications and the effect on hospital stay, elective TT is the choice for perioperative airway management in high-risk patients [16].

There are different approaches in the form of scoring systems that help define high-risk patients and determine those who may actually benefit from elective TT. We retrospectively applied two different scoring systems published by Cameron et al. and Mohamedbhai et al. with the intent of determining if there is an over-indication of elective TT in our institution.​​ The choice of these scoring systems was due to their incorporation of surgical and reconstruction factors and making their use easy and practical for surgeons [4,6]. These scoring systems consider that TT is recommended when a certain score is surpassed, and a higher score is associated with a higher risk of airway obstruction. According to the Cameron scoring system and the TRACHY score, recommendation for tracheostomy coincided in only 54.3% and 45.7%, respectively, in our population. Also, a considerable number of patients had low scores of zero and one when scoring systems were applied. For this reason, we conclude that our department has a lower threshold for elective TT, potentially leading to an over-indication of TT in our population. This is evident as only approximately half of the cases would have met the recommendation had the scoring system been applied prior to the operation.

We then questioned what patients could have possibly avoided elective TT. Despite acknowledging that time until decannulation can be influenced by factors such as the time until predicated discharge and the potential of a new surgical intervention, we postulated that patients in the ≤7 days until decannulation group were those who could have more probably foregone elective TT. Our results found that tumor anatomy and type of reconstruction were associated with less time until decannulation. For this reason, we conclude that the patients who could have avoided elective TT are those with lateral anatomy and with primary closure or a fasciocutaneous flap. Additionally, we evaluated the group of patients that did not have a recommendation for elective TT in each score and determined that for both scores, anatomy, site, and N-stage were associated with less time until decannulation, as well as T-stage in those without TT indication in the Cameron score. As the previous analysis, those with lateral anatomy were significantly associated with earlier cannula removal. Those with mandibular alveolus and anterior tongue location sites were also associated with less time until decannulation as well as T-stage T1/T2 and N-stage N0/N1. We believe that patients with these characteristics could have potentially avoided elective TT.

While scoring systems offer valuable guidance, forecasting the necessity for elective TT remains a challenging endeavor for individual patients. Furthermore, scoring systems have not consistently persuaded clinicians in practical clinical settings [17,18]. The need for additional research and validation through prospective multicentre randomized controlled trials persists, particularly in understanding the fallibility rates and achieving the universal acceptance of these scores as exclusive selection methods. Most importantly, even with the assistance of scoring systems, the choice of elective TT is executed individually for each patient and is profoundly dependent on the experience of the surgical team.

This study has some limitations. First, it was a single hospital and retrospective study. The accuracy of data collected from clinical records is always an important issue, as well as the absence of a control group. An additional limitation is the lack of consideration for both the surgeons involved and intraoperative complications, such as the need for jugular ligation or thrombosis of the lingual veins, which could have impacted the indication for TT. Future studies should include a prospective study in which the scoring systems were applied preoperatively to one group of patients to evaluate their usefulness in determining the best patients for elective TT. Additionally, management of the postoperative airway with delayed extubation has been safely proven in patients undergoing oral surgery, so we believe it would be beneficial to study this option in those patients without TT indication [19]. Finally, we chose this timeframe because it contains the latest accurate and comprehensive clinical data records. Furthermore, it includes the extended duration required for ethical approval, along with the time dedicated to data collection and article completion.

Conclusions

Postoperative airway management in our institution is performed in a safe and controlled manner seeing as the overall TT-associated complication rate is on the lower end of the literature.

Our department appeared to have a lower threshold for elective TT, potentially leading to an over-indication of TT in our patients with oral cavity and oropharyngeal cancer when scores were applied. The patients that could have potentially foregone elective TT were those with lateral anatomy, without flap or with fasciocutaneous flap, location in the mandibular alveolus, or anterior tongue, as well as N0/N1 and T1/T2 patients. 

We conclude that a prior analysis of each patient using the scores proposed in the literature can help in the decision of whether to perform a prophylactic tracheostomy. Ultimately, an individual analysis must be taken into account whenever a postoperative period with more complicated airway management is foreseen. We hope our study will aid other clinicians in questioning their indications for elective tracheostomy, in order to give these patients the best perioperative airway management.

Acknowledgments

Diana Breda and Sara Martins contributed equally to the work and should be considered co-first authors.

The authors have declared that no competing interests exist.

Author Contributions

Concept and design:  Diana Breda, Sara Martins, Ana Millán, Sandra Bitoque, Carlos Zagalo, Pedro Gomes

Acquisition, analysis, or interpretation of data:  Diana Breda, Sara Martins

Drafting of the manuscript:  Diana Breda, Sara Martins, Ana Millán, Sandra Bitoque, Carlos Zagalo, Pedro Gomes

Critical review of the manuscript for important intellectual content:  Diana Breda, Sara Martins, Ana Millán, Sandra Bitoque, Carlos Zagalo, Pedro Gomes

Supervision:  Diana Breda, Sara Martins, Ana Millán, Sandra Bitoque, Carlos Zagalo, Pedro Gomes

Human Ethics

Consent was obtained or waived by all participants in this study. Ethics Committee of the Portuguese Institute of Oncology of Lisbon issued approval UIC/1579

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.Early postoperative care for free flap head &amp; neck reconstructive surgery - a national survey of practice. Marsh M, Elliott S, Anand R, Brennan PA. Br J Oral Maxillofac Surg. 2009;47:182–185. doi: 10.1016/j.bjoms.2008.06.004. [DOI] [PubMed] [Google Scholar]
  • 2.Analysis of tracheostomy-associated morbidity after operations for head and neck cancer. Halfpenny W, McGurk M. Br J Oral Maxillofac Surg. 2000;38:509–512. doi: 10.1054/bjom.2000.0310. [DOI] [PubMed] [Google Scholar]
  • 3.Airway management and postoperative length of hospital stay in patients undergoing head and neck cancer surgery. Siddiqui AS, Dogar SA, Lal S, Akhtar S, Khan FA. J Anaesthesiol Clin Pharmacol. 2016;32:49–53. doi: 10.4103/0970-9185.173341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.TRACHY score: a simple and effective guide to management of the airway in head and neck cancer. Mohamedbhai H, Ali S, Dimasi I, Kalavrezos N. Br J Oral Maxillofac Surg. 2018;56:709–714. doi: 10.1016/j.bjoms.2018.07.015. [DOI] [PubMed] [Google Scholar]
  • 5.Factors contributing to delayed decannulation of temporary tracheostomies following free tissue reconstructive surgery for head and neck cancer. Littlewood CG, Jebril A, Lowe D, Konig R, Groom P, Rogers SN. Br J Oral Maxillofac Surg. 2021;59:472–477. doi: 10.1016/j.bjoms.2020.09.019. [DOI] [PubMed] [Google Scholar]
  • 6.Development of a tracheostomy scoring system to guide airway management after major head and neck surgery. Cameron M, Corner A, Diba A, Hankins M. Int J Oral Maxillofac Surg. 2009;38:846–849. doi: 10.1016/j.ijom.2009.03.713. [DOI] [PubMed] [Google Scholar]
  • 7.Complications of tracheostomy in major head and neck cancer surgery; a retrospective study of 60 consecutive cases. Castling B, Telfer M, Avery BS. Br J Oral Maxillofac Surg. 1994;32:3–5. doi: 10.1016/0266-4356(94)90162-7. [DOI] [PubMed] [Google Scholar]
  • 8.Temporary tracheotomy in microvascular reconstruction in maxillofacial surgery: benefit or threat? Goetz C, Burian NM, Weitz J, Wolff KD, Bissinger O. J Craniomaxillofac Surg. 2019;47:642–646. doi: 10.1016/j.jcms.2019.01.017. [DOI] [PubMed] [Google Scholar]
  • 9.Tracheotomy-related deaths. Klemm E, Nowak AK. Dtsch Arztebl Int. 2017;114:273–279. doi: 10.3238/arztebl.2017.0273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Tracheostomy: experience at tertiary hospital. Chavan RP, Ingole SM, Mane B, Kalekar TM, Birajdar SN. Indian J Otolaryngol Head Neck Surg. 2019;71:580–584. doi: 10.1007/s12070-018-1417-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.An overview of complications associated with open and percutaneous tracheostomy procedures. Cipriano A, Mao ML, Hon HH, Vazquez D, Stawicki SP, Sharpe RP, Evans DC. Int J Crit Illn Inj Sci. 2015;5:179–188. doi: 10.4103/2229-5151.164994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Evaluation of early postoperative complications following tracheotomy. Freburg-Hoffmeister DL, Hardeman JH, Dolwick MF, Widmer CG. J Oral Maxillofac Surg. 2017;75:2701–2706. doi: 10.1016/j.joms.2017.05.009. [DOI] [PubMed] [Google Scholar]
  • 13.Tracheostomy complications and their management. Mehta AK, Chamyal PC. Med J Armed Forces India. 1999;55:197–200. doi: 10.1016/S0377-1237(17)30440-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Tracheotomy complications: a retrospective study of 1130 cases. Goldenberg D, Ari EG, Golz A, Danino J, Netzer A, Joachims HZ. Otolaryngol Head Neck Surg. 2000;123:495–500. doi: 10.1067/mhn.2000.105714. [DOI] [PubMed] [Google Scholar]
  • 15.Retrospective study of tracheostomy indications and perioperative complications on oral and maxillofacial surgery service. Haspel AC, Coviello VF, Stevens M. J Oral Maxillofac Surg. 2012;70:890–895. doi: 10.1016/j.joms.2011.09.022. [DOI] [PubMed] [Google Scholar]
  • 16.Elective tracheostomy in head and neck surgery: our experience. Anehosur VS, Karadiguddi P, Joshi VK, Lakkundi BC, Ghosh R, Krishnan G. J Clin Diagn Res. 2017;11:0–9. doi: 10.7860/JCDR/2017/24117.9854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.The evaluation of a scoring system in airway management after oral cancer surgery. Lee HJ, Kim JW, Choi SY, Kim CS, Kwon TG, Paeng JY. Maxillofac Plast Reconstr Surg. 2015;37:19. doi: 10.1186/s40902-015-0021-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Protocol based evaluation for feasibility of extubation compared to clinical scoring systems after major oral cancer surgery safely reduces the need for tracheostomy: a retrospective cohort study. Schmutz A, Dieterich R, Kalbhenn J, Voss P, Loop T, Heinrich S. BMC Anesthesiol. 2018;18:43. doi: 10.1186/s12871-018-0506-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Identification of patients for a delayed extubation strategy versus elective tracheostomy for postoperative airway management in major oral cancer surgery: a prospective observational study in seven hundred and twenty patients. Myatra SN, Gupta S, D'Cruz AK, Rajanala V, Dhar H, Sharma S, Divatia JV. Oral Oncol. 2021;121:105502. doi: 10.1016/j.oraloncology.2021.105502. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES